#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Basal cell naevus syndrome Mantle cell lymphoma Krabbe's disease Rett syndrome Small for dates baby Myeloproliferative neoplasm Gestational trophoblastic tumour Liver abscess Arterial tortuosity syndrome Factor VIII deficiency Adenovirus infection Acromegaly Glycogen storage disease type II Ductal adenocarcinoma of pancreas Cholestatic pruritus More trials…

    Learn about Rare Diseases

    Hereditary hypophosphataemic rickets – Trials in Disease Tuberous sclerosis complex – Diagnostics Leiomyosarcoma recurrent – Basic Information Ewing’s sarcoma metastatic – Basic Information Bronchiolitis obliterans syndrome – Basic Information Urea cycle disorder – Diagnostics Ewing’s sarcoma – Life with Disease Mitochondrial myopathy Pyogenic sterile arthritis pyoderma gangrenosum and acne syndrome – Basic Information Congenital nephrogenic diabetes insipidus More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    GSKVX000000030825 Imifoplatin Ketamine Hydrochloride OMTX705 Seladelpar GSKVX000000034794 LY3537031 Protease Enasidenib Mesilate Bevacizumab Carbamazepine Nacubactam Iopromide Bi 685509 Sibeprenlimab A3907 Enfuvirtide Caba-201 4-Hydroxy-N-Desmethyltamoxifen Sodium Alginate More therapies…

    Learn about Your Condition

    Metastatic malignant melanoma Skin wrinkling Oesophagectomy Plasma cell leukaemia Anal abscess Colitis Peripheral spondyloarthritis Type 1 diabetes mellitus Muscle injury Follicular thyroid cancer Haemorrhage Microvillous inclusion disease Liposarcoma Cholecystitis acute Vesicoureteric reflux More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Uncategorized

  • Assessment of NBI-1065845 as an Additional Treatment for Adults with Major Depressive Disorder

    Recruiting

    3 1
    Investigated Diseases:
    • Major depression
    Investigated Drugs:
    • 9-(4-CYCLOHEXYLOXYPHENYL)-7-METHYL-3,4-DIHYDROPYRAZINO[2,1-C][1,2,4]THIADIAZINE 2,2-DIOXIDE
    Bulgaria Lithuania Romania Slovakia

  • Efficacy of 177Lu-DOTATATE as Adjuvant Therapy After Surgery for Stage III Small Intestinal Neuroendocrine Tumors

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Small intestine neuroendocrine tumour
    Investigated Drugs:
    • Lutetium (177Lu) Oxodotreotide
    Germany

  • Study on the Safety and Effectiveness of BNT327 and Docetaxel for Patients with Advanced Non-Small Cell Lung Cancer After Chemoimmunotherapy

    Recruiting

    2 1 1 1
    Investigated Drugs:
    • BNT327
    • Docetaxel
    Spain

  • Study on Atorvastatin’s Role in Enhancing Immunotherapy for Patients with Triple Negative Breast Cancer and Non-Small Cell Lung Cancer

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Non-small cell lung cancer stage IIIB
    • Non-small cell lung cancer stage IV
    • Triple negative breast cancer
    Investigated Drugs:
    • Atorvastatin
    Italy

  • Study on Reduction of Toxicant Levels in Blood through Combined Digestive Decontamination with Activated Charcoal and Intestinal Purge for Intubated Patients with Major Poisoning in Intensive Care

    Recruiting

    2 1 1 1
    Investigated Drugs:
    • Charcoal, Activated
    • Macrogol 4000
    • Sodium Hydrogen Carbonate
    France

  • Study of Telisotuzumab Adizutecan for Adults with Colorectal Cancer Who Have Positive Circulating Tumor DNA After Treatment but No Visible Cancer on Scans

    Recruiting

    2 1 1
    Investigated Diseases:
    • Colorectal cancer
    Belgium Denmark Italy Spain
Previous Page
1 … 171 172 173 174 175 … 1,648
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!